Takeda Pharmaceutical Co. Ltd. · TSE:4502
Kim Julie So-Young sold 89,090 Takeda Pharmaceutical Co. Ltd. shares (Form 4)
Traded Aug 10, 2026 · Filed Aug 12, 2026
On Aug 10, 2026, Kim Julie So-Young (Director, President and CEO) sold 89,090 Takeda Pharmaceutical Co. Ltd. shares at US$17.10 for US$1.52M, leaving 391,489 shares. Filed Aug 12, 2026 (Form 4).
- Sold
- 89,090 shares
- Price
- US$17.10
- Value
- US$1.52M
- Holding after
- 391,489 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 10, 2026 | American Depositary Shares | Sale | 89,090 | US$17.10 | 391,489 | Direct |
Source
Related
- Takeda Pharmaceutical Co. Ltd.
- Kim Julie So-Young
- Takeda Pharmaceutical Co. Ltd. shareholders
- Form 4 · Kim Julie So-Young · Jul 6, 2026
- Form 4 · Kim Julie So-Young · Apr 28, 2026
- Form 4 · Duprey Lauren Rusckowski · Sep 15, 2026
- Form 4 · Plump Andrew Stewart · Sep 3, 2026
- Form 4 · Plump Andrew Stewart · Aug 21, 2026
- Form 4 · Greenway Nicola Deidre Petal · Aug 19, 2026
- Form 4 · Shannon Elaine Mary · Aug 12, 2026